Pulmonary nontuberculous mycobacterial infections among women with cystic fibrosis and non-cystic fibrosis bronchiectasis
Therapeutic Advances in Respiratory Disease · 2025-01 · 19
DOI: 10.1177/17534666251323181 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Therapeutic Advances in Respiratory Disease, online erschienen am 12.03.2025. Verfasst von Jane E Gross und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of North Carolina, 333 South Columbia Street, 450 MacNider, CB# 7217, Chapel Hill, NC 27599, USA. Hauptthemen laut MEDLINE: Mycobacterium Infections, Nontuberculous, Cystic Fibrosis, Bronchiectasis. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Division of Intramural Research, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Nontuberculous mycobacteria (NTM) are ubiquitous, opportunistic pathogens that can cause lung disease in people with non-cystic fibrosis bronchiectasis (NCFB) and cystic fibrosis (CF). The incidence of NTM pulmonary infections and lung disease has continued to increase worldwide over the last decade among both groups. Notably, women with NCFB NTM pulmonary disease (NTM-PD) bear a disproportionate burden with NTM rates increasing in this population as well as having consistently higher incidence of NTM-PD compared to men. In contrast, among people with CF, an overall increased risk among women has not been observed. In the United States, the majority of people with CF are taking highly effective cystic fibrosis transmembrane conductance regulator (CFTR) modulators, and these numbers are increasing worldwide. The long-term impact of CFTR modulator medications on NTM infections is not entirely understood. Guidelines for the screening, diagnosis, and management of NTM-PD exist for people with NCFB and CF, but do not consider unique implications relevant to women. This review highlights aspects of NTM-PD among women with NCFB and CF, including the epidemiology of NTM infection, special considerations for treatment, and unmet research needs relevant to women with NTM-PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, University of North Carolina, 333 South Columbia Street, 450 MacNider, CB# 7217, Chapel Hill, NC 27599, USA.
- Department of Pharmacy, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
- Epidemiology and Population Studies Section, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
- Department of Medicine, National Jewish Health, Denver, CO, USA.
- Department of Medicine, University of Colorado, Aurora, CO, USA.
ORCID-Profile: Jane E Gross
Förderung
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Zitieren
APA
Gross, J. E., Jones, M. C., Buige, A., Prevots, D. R., & Kasperbauer, S. (2025). Pulmonary nontuberculous mycobacterial infections among women with cystic fibrosis and non-cystic fibrosis bronchiectasis. Therapeutic Advances in Respiratory Disease, 19. https://doi.org/10.1177/17534666251323181
Vancouver
Gross JE, Jones MC, Buige A, Prevots DR, Kasperbauer S. Pulmonary nontuberculous mycobacterial infections among women with cystic fibrosis and non-cystic fibrosis bronchiectasis. Therapeutic Advances in Respiratory Disease. 2025;19. doi:10.1177/17534666251323181
BibTeX
@article{Gross2025,
author = {Gross, Jane E and Jones, Morgan C and Buige, Ashley and Prevots, D Rebecca and Kasperbauer, Shannon},
title = {Pulmonary nontuberculous mycobacterial infections among women with cystic fibrosis and non-cystic fibrosis bronchiectasis},
journal = {Therapeutic Advances in Respiratory Disease},
year = {2025},
volume = {19},
doi = {10.1177/17534666251323181}
}
EUVIMED